This announcement was made alongside the reveal of positive Phase 3 results for Tanruprubart, a monoclonal antibody that can block C1q and can potentially halt neuroinflammation and nerve damage in ...

A hospital trust has apologised for the 'distress and trauma' after an 11-year-old girl has been awarded a £35 million ...

The primary endpoint, outcome on the GBS Disability Score (GBS-DS) at 8 weeks, showed 29% of patients treated with tanruprubart at a dose of 30 mg/kg recovered to a healthy state with a score of 0 or ...

A future in lacrosse was in doubt for River Hill girls lacrosse’s Gabby Bergstrom when she was diagnosed with Guillain-Barré ...

Annexon achieved primary endpoints in two Phase 3 studies for tanruprubart in treating Guillain-Barre Syndrome, setting the stage for a pre-BLA meeting ...

As it advances a monoclonal antibody targeting Guillain-Barré syndrome (GBS), Annexon Biosciences is embarking on another effort to improve treatment of the rare condition. | As it advances a ...

As the 2020 pandemic became a distant memory and millions of Americans returned back to their old lives, some were left ...

022). This interesting study suggests that patients whose IgG levels increase less after treatment of GBS with IVIg have worse outcomes compared with those who have larger increases in IgG.

Pune: The sewage treatment capacity of PMC is set to increase soon as the civic administration has decided to augment the ...